Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
3 min read
Sandoz's Tyruko® (natalizumab), a unique biosimilar for multiple sclerosis, has been approved by the European Commission
1 October 2023
Sandoz gains consent from the European Commission for its unique multiple sclerosis biosimilar, Tyruko® (natalizumab) in Europe.
Drug Insights
4 min read
Nalidixic Acid Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
1 October 2023
This article summarized the latest R&D progress of Nalidixic Acid, the Mechanism of Action for Nalidixic Acid, and the drug target R&D trends for Nalidixic Acid.
Valuable Targets
5 min read
Potent "bone-protecting drugs" - RANKL inhibitors
1 October 2023
RANKL, or Receptor Activator of Nuclear Factor Kappa-B Ligand, is a crucial protein involved in the regulation of bone metabolism in the human body.
Drug Insights
4 min read
Unleashing the Power of Naphazoline Hydrochloride: A Comprehensive Review on R&D Breakthroughs
1 October 2023
This article summarized the latest R&D progress of Naphazoline Hydrochloride, the Mechanism of Action for Naphazoline Hydrochloride, and the drug target R&D trends for Naphazoline Hydrochloride.
Latest Hotspot
3 min read
Lantern Pharma reports initial patient treated in the Phase 1 trial of LP-184 for Advanced Solid Malignancies
1 October 2023
Lantern Pharma Inc. has started Phase 1 clinical trial on its experimental drug, LP-184, for advanced solid tumors. This is part of the company's ongoing clinical drug development.
Drug Insights
4 min read
A Comprehensive Review of Phenazepam's R&D Innovations and Drug Target Mechanism
1 October 2023
This article summarized the latest R&D progress of Phenazepam, the Mechanism of Action for Phenazepam, and the drug target R&D trends for Phenazepam.
Advanced Tech.
6 min read
Advances in Clinical Research on PrEP drug
1 October 2023
Pre-exposure prophylaxis (PrEP) is a preventive measure that involves the use of antiretroviral drugs to reduce the risk of HIV infection in individuals who are not infected but are at high risk of exposure.
Drug Insights
4 min read
Pharmaceutical Insights: Phendimetrazine Tartrate's R&D Progress
1 October 2023
This article summarized the latest R&D progress of Phendimetrazine Tartrate, the Mechanism of Action for Phendimetrazine Tartrate, and the drug target R&D trends for Phendimetrazine Tartrate.
Latest Hotspot
3 min read
Escient Pharmaceuticals is now conducting a trial-based study on EP262, a groundbreaking oral MRGPRX2 blocker for chronic hives
1 October 2023
Escient Pharmaceuticals commences trial-based study of EP262, an innovative, orally-taken MRGPRX2 blocker for chronic inducible hives.
Drug Insights
4 min read
Exploring Prednisolone Sodium Phosphate's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
1 October 2023
This article summarized the latest R&D progress of Prednisolone Sodium Phosphate, the Mechanism of Action for Prednisolone Sodium Phosphate, and the drug target R&D trends for Prednisolone Sodium Phosphate.
"What" Series
2 min read
What is EC in Life Sciences?
1 October 2023
The full name is the Ethics Committee, an independent organization composed of medical professionals, legal experts, and non-medical personnel.
Drug Insights
4 min read
Decoding Risdiplam: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
1 October 2023
This article summarized the latest R&D progress of Risdiplam, the Mechanism of Action for Risdiplam, and the drug target R&D trends for Risdiplam.